(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DUSKEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DUSKEN

ST13

US500000090585037

Class

5

Filing

90585037

Registration

6806282

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

23

Latest update

10/28/2022

Trademark type

Word

Nice classes

5

Filing date

03/17/2021

Registration date

08/02/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/02/2022

Last transaction

10/28/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

Milano (MI), IT

Examiner

CERDA, VICTOR

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

ITALFARMACO SPA

Representatives

Courtney Thompson FREDRIKSON & BYRON

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Biochemical and chemical preparations for medical usechemical reagents for medical purposes and excipients in a liquid formulation for oral administration; biological preparations for medical use for the treatment of neurological and psychiatric diseasescancerinflammatory diseasesHIV/AIDSspinal muscular atrophysystemic juvenile idiopathic arthritispolycythaemia veraessential thrombocythemialeukemiasmyelomasmyelofibrosisDuchenne muscular dystrophyBecker muscular dystrophy and other forms of muscular dystrophy; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders; pharmaceutical products for the treatment of genetic disorders

Publications

History of USPTO decisions and trademark events.

23 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/02/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

08/02/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/17/2022

PUBO

PUBLISHED FOR OPPOSITION

05/17/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/27/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/14/2022

DOCK

ASSIGNED TO EXAMINER

02/15/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/26/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/26/2022

ALIE

ASSIGNED TO LIE

01/26/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

01/21/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/20/2022

GNSL

LETTER OF SUSPENSION E-MAILED

01/20/2022

CNSL

SUSPENSION LETTER WRITTEN

01/20/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/23/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/23/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/23/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/22/2021

GNRT

NON-FINAL ACTION E-MAILED

10/22/2021

CNRT

NON-FINAL ACTION WRITTEN

10/22/2021

DOCK

ASSIGNED TO EXAMINER

10/18/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/17/2021

NWAP

NEW APPLICATION ENTERED

03/20/2021

Continuous trademark protection

Get notified about every new filing that threatens DUSKEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.